Skip to main content
OpenTrials

Clinical trial condition

Hereditary Angioedema (HAE)

Explore clinical trials studying Hereditary Angioedema (HAE). Study availability and eligibility vary by location and protocol.

54 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Angioedema (HAE) trial results

Completed

A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)

NCT05460325

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
  • Yantai Yuhuangding Hospital Yantai, Shandong, China
  • Peking Union Medical College Hospital Beijing, China
View Trial Details
Completed

Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

NCT01034969

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Campbelltown Hospital Campbelltown, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Medizinische Universität Graz Graz, Austria
  • Faculdade de Medicina Do ABC Santo André, São Paulo, Brazil
View all 74 locations
View Trial Details
Completed

A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada

NCT05578417

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Alberta Health Services Calgary, Alberta, Canada
  • Alberta Health Services Edmonton, Alberta, Canada
  • Vancouver Allergy Clinic Vancouver, British Columbia, Canada
  • University of Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Completed

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

NCT03845400

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • AIRE Medical of Los Angeles Santa Monica, California, United States
View all 29 locations
View Trial Details
Completed

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

NCT04861090

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • LKH-Universitätsklinikum Klinikum Graz Graz, Austria
  • Kepler Universitätsklinikum Linz Linz, Austria
  • Medizinische Universitat Wien (Medical University of Vienna) Vienna, Austria
  • CHU de Grenoble Grenoble, France
View all 20 locations
View Trial Details
Completed

Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)

NCT04180163

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Toyohashi Municipal Hospital Toyohashi, Aichi-ken, Japan
  • Asahi General Hospital Asahi-shi, Chiba, Japan
  • Ogaki Municipal Hospital Ogaki-shi, Gifu, Japan
  • Hiroshima University Hospital Hiroshima, Japan
View Trial Details
Completed

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

NCT00456508

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Aaron Davis Scottsdale, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Little Rock Allergy & Asthma Clinic Little Rock, Arkansas, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
View all 41 locations
View Trial Details

Related conditions